COMMUNIQUÉ DE PRESSE publié le 27/10/2025 à 18:59, il y a 1 année Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of 20,000 of its 'A' Ordinary Shares as part of share buyback programme. Shares to be held in Treasury Share Buyback Treasury Fuller Smith Turner
BRÈVE publiée le 23/10/2025 à 18:35, il y a 1 année Fuller, Smith & Turner PLC: Share Buyback Activity Voting Rights Share Buyback Treasury Shares Market Regulation Fuller’s
BRÈVE publiée le 23/10/2025 à 18:35, il y a 1 année Fuller, Smith & Turner PLC : activité de rachat d'actions Actions Propres Rachat D'actions Droit De Vote Régulation Du Marché Fuller
COMMUNIQUÉ DE PRESSE publié le 23/10/2025 à 18:30, il y a 1 année Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of 3,000 of its own "A" Ordinary Shares at an average price of 600.0000 GBp per share, as part of share buyback program Voting Rights London Stock Exchange Share Buyback Fuller, Smith & Turner PLC Numis Securities Limited
BRÈVE publiée le 22/10/2025 à 18:46, il y a 1 année Fuller, Smith & Turner PLC Executes Share Buyback London Stock Exchange Ordinary Shares Share Buyback Treasury Shares Fuller's
BRÈVE publiée le 22/10/2025 à 18:46, il y a 1 année Fuller, Smith & Turner PLC procède à un rachat d'actions Actions Propres Rachat D'actions Actions Ordinaires Bourse De Londres Fuller
COMMUNIQUÉ DE PRESSE publié le 22/10/2025 à 18:41, il y a 1 année Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 5,000 of its 'A' Ordinary Shares as part of a share buyback programme London Stock Exchange Fuller, Smith & Turner PLC Share Buyback Programme Numis Securities Limited Regulatory Announcement
BRÈVE publiée le 21/10/2025 à 19:02, il y a 1 année Fuller, Smith & Turner PLC: Share Buyback Details Voting Rights London Stock Exchange Ordinary Shares Share Buyback Fuller, Smith & Turner
BRÈVE publiée le 21/10/2025 à 19:02, il y a 1 année Fuller, Smith & Turner PLC : détails du rachat d'actions Rachat D'actions Droit De Vote Actions Ordinaires Bourse De Londres Fuller, Smith Et Turner
COMMUNIQUÉ DE PRESSE publié le 21/10/2025 à 18:57, il y a 1 année Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of own shares as part of share buyback program, holding 4,081,980 shares in Treasury. Detailed transaction information provided London Stock Exchange Share Buyback Program Fuller, Smith & Turner PLC Numis Securities Limited Own Shares
Publié le 04/11/2026 à 18:00, il y a 8 heures 38 minutes The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Publié le 04/11/2026 à 18:00, il y a 8 heures 38 minutes L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Publié le 04/11/2026 à 17:44, il y a 8 heures 54 minutes Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
Publié le 04/11/2026 à 23:10, il y a 3 heures 28 minutes Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Publié le 04/11/2026 à 23:00, il y a 3 heures 38 minutes Viemed Healthcare Announces Third Quarter 2026 Financial Results
Publié le 04/11/2026 à 22:15, il y a 4 heures 23 minutes Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Publié le 04/11/2026 à 22:05, il y a 4 heures 33 minutes Stabilis Solutions Announces Third Quarter 2026 Results
Publié le 05/11/2026 à 00:02, il y a 2 heures 35 minutes EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Publié le 04/11/2026 à 19:41, il y a 6 heures 57 minutes EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Publié le 04/11/2026 à 19:25, il y a 7 heures 13 minutes Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Publié le 04/11/2026 à 18:43, il y a 7 heures 55 minutes EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Publié le 04/11/2026 à 18:05, il y a 8 heures 33 minutes Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production
